Neumora Therapeutics Income Tax

The latest income tax for NMRA is $30K as of June 2026. That compares with $180K in the prior-year period — down 83.6% year over year. Investors often review this figure alongside Neumora Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMRA's income tax moved from $180K to $30K — a 83.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Neumora Therapeutics's operating scale or balance-sheet position.

A income tax figure of $30K for NMRA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NMRA's income tax ($30K), review year-over-year change from $180K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.